Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial

This publication has 13 references indexed in Scilit:

• Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure
  Journal of Cardiac Failure, 1998
• Hemodynamic and Renal Excretory Effects of Human Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure
  Circulation, 1996
• Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy
  Hypertension, 1996
• Hemodynamic Effects of a Single Intravenous Injection of Synthetic Human Brain Natriuretic Peptide in Patients With Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
  The American Journal of Cardiology, 1996
• Pressure and Volume Loading of the Right Ventricle Have Opposite Effects on Left Ventricular Ejection Fraction
  Circulation, 1995
• Receptor guanylyl cyclases.
  Journal of Clinical Investigation, 1992
• Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.
  Hypertension, 1991
• Brain Natriuretic Peptide Administered to Man: Actions and Metabolism*
  Journal of Clinical Endocrinology & Metabolism, 1990
• Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure
  Journal of the American College of Cardiology, 1990
• Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to Coronary artery disease or idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1986